AWIN INTERNATIONAL TRADING LIMITED – Trademark Portfolio

Entity Type: 99

AWIN INTERNATIONAL TRADING LIMITED holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include SCLA, FAYOUNG, and GENEVER. The owner is based in HK.

LEVEL 54, HOPEWELL CENTRE, 183 QUEEN'S

ROAD, EAST

HK 999077 , HK

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SCLA
SCLA
Registered 2022
GENEVER
GENEVER
Registered 2022
FAYOUNG
FAYOUNG
Registered 2021

Trademark Classifications

AWIN INTERNATIONAL TRADING LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does AWIN INTERNATIONAL TRADING LIMITED have?

AWIN INTERNATIONAL TRADING LIMITED has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does AWIN INTERNATIONAL TRADING LIMITED file in?

AWIN INTERNATIONAL TRADING LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are AWIN INTERNATIONAL TRADING LIMITED's most well-known trademarks?

AWIN INTERNATIONAL TRADING LIMITED's registered trademark portfolio includes well-known marks such as SCLA, FAYOUNG, and GENEVER. These are among 3 currently registered trademarks in the portfolio.

What is AWIN INTERNATIONAL TRADING LIMITED's trademark registration success rate?

AWIN INTERNATIONAL TRADING LIMITED has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.